Use of compounds, known to activate insulin receptors, to treat disorders due to the administration of human immunodeficiency virus protease inhibitors, e.g. insulin resistance, diabetes, keto-acidosis or lipodystrophia

摘要

The use of a compounds that activates insulin receptors in medicines for the treatment of disorders due to the administration of an human immunodeficiency virus (HIV) protease inhibitor. The use of a compounds that activates insulin receptors in medicines for the treatment of disorders due to the administration of an HIV protease inhibitor, especially compounds of formulae (I), (II), (III), (IV), (V), (VI) and (VII), their salts or stereoisomers: For Full Definitions see Definition field. Independent claims are included for: (1) A composition (II), comprising a compound of formula (I) - (VII); and (2) A method of treating disorders due to the administration of an HIV protease inhibitor, comprising administration of a compound of formula (I) - (VII).